Table of Contents Global Erythropoietin (EPO) Drugs Market Research Report 2022, Forecast to 2027 1 Market Study Overview 1.1 Study Objectives 1.2 Erythropoietin (EPO) Drugs Introduce 1.3 Combined with the Analysis of Macroeconomic Indicators 1.4 Brief Description of Research methods 1.5 Market Breakdown and Data Triangulation 2 Global Trend Summary 2.1 Erythropoietin (EPO) Drugs Segment by Type 2.1.1 Epoetin-alfa 2.1.2 Darbepoetin-alfa 2.1.3 Epoetin-beta 2.1.4 Others 2.2 Market Analysis by Application 2.2.1 Anemia 2.2.2 Kidney Disorders 2.2.3 Other 2.3 Global Erythropoietin (EPO) Drugs Market Comparison by Regions (2017-2027) 2.3.1 Global Erythropoietin (EPO) Drugs Market Size (2017-2027) 2.3.2 North America Erythropoietin (EPO) Drugs Status and Prospect (2017-2027) 2.3.3 Europe Erythropoietin (EPO) Drugs Status and Prospect (2017-2027) 2.3.4 China Erythropoietin (EPO) Drugs Status and Prospect (2017-2027) 2.3.5 Japan Erythropoietin (EPO) Drugs Status and Prospect (2017-2027) 2.3.6 Southeast Asia Erythropoietin (EPO) Drugs Status and Prospect (2017-2027) 2.4 Basic Product Information 2.4.1 Basic Product Information & Technology Development History 2.4.2 Product Manufacturing Process 2.4.3 Interview with Major Market Participants 2.4.4 High-end Market Analysis and Forecast 2.5 Coronavirus Disease 2019 (Covid-19): Erythropoietin (EPO) Drugs Industry Impact 2.5.1 Erythropoietin (EPO) Drugs Business Impact Assessment - Covid-19 2.5.2 Market Trends and Erythropoietin (EPO) Drugs Potential Opportunities in the COVID-19 Landscape 2.5.3 Measures / Proposal against Covid-19 3 Competition by Manufacturer 3.1 Global Erythropoietin (EPO) Drugs Sales and Market Share by Manufacturer (2017-2022) 3.2 Global Erythropoietin (EPO) Drugs Revenue and Market Share by Manufacturer (2017-2022) 3.3 Global Erythropoietin (EPO) Drugs Industry Concentration Ratio (CR5 and HHI) 3.4 Top 5 Erythropoietin (EPO) Drugs Manufacturer Market Share 3.5 Top 10 Erythropoietin (EPO) Drugs Manufacturer Market Share 3.6 Date of Key Manufacturers Enter into Erythropoietin (EPO) Drugs Market 3.7 Key Manufacturers Erythropoietin (EPO) Drugs Key Manufacturers 3.8 Mergers & Acquisitions Planning 4 Analysis of Erythropoietin (EPO) Drugs Industry Key Manufacturers 4.1 Amgen 4.1.1 Compan Detail 4.1.2 Amgen Erythropoietin (EPO) Drugs Product Introduction, Application and Specification 4.1.3 Amgen 138 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.1.4 Main Business Overview 4.1.5 Amgen News 4.2 Johnson & Johnson 4.2.1 Compan Detail 4.2.2 Johnson & Johnson Erythropoietin (EPO) Drugs Product Introduction, Application and Specification 4.2.3 Johnson & Johnson Erythropoietin (EPO) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.2.4 Main Business Overview 4.2.5 Amgen News 4.3 Roche 4.3.1 Compan Detail 4.3.2 Roche Erythropoietin (EPO) Drugs Product Introduction, Application and Specification 4.3.3 Roche Erythropoietin (EPO) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.3.4 Main Business Overview 4.3.5 Roche News 4.4 Galenica 4.4.1 Compan Detail 4.4.2 Galenica Erythropoietin (EPO) Drugs Product Introduction, Application and Specification 4.4.3 Galenica Erythropoietin (EPO) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.4.4 Main Business Overview 4.4.5 Galenica News 4.5 Emcure 4.5.1 Compan Detail 4.5.2 Galenica Erythropoietin (EPO) Drugs Product Introduction, Application and Specification 4.5.3 Emcure Erythropoietin (EPO) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.5.4 Main Business Overview 4.5.5 Emcure News 4.6 Kyowa Hakko Kirin 4.6.1 Compan Detail 4.6.2 Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Product Introduction, Application and Specification 4.6.3 Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.6.4 Main Business Overview 4.6.5 Kyowa Hakko Kirin News 4.7 3SBio 4.7.1 Compan Detail 4.7.2 3SBio Erythropoietin (EPO) Drugs Product Introduction, Application and Specification 4.7.3 3SBio Erythropoietin (EPO) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.7.4 Main Business Overview 4.7.4 Main Business Overview 4.8 Biocon 4.8.1 Compan Detail 4.8.2 Biocon Erythropoietin (EPO) Drugs Product Introduction, Application and Specification 4.8.3 Biocon Erythropoietin (EPO) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.8.4 Main Business Overview 4.8.5 Biocon News 4.9 LG Life Sciences 4.9.1 Compan Detail 4.9.2 LG Life Sciences Erythropoietin (EPO) Drugs Product Introduction, Application and Specification 4.9.3 LG Life Sciences Erythropoietin (EPO) Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.9.4 Main Business Overview 4.9.5 LG Life Sciences News 5 Global Erythropoietin (EPO) Drugs Market Segment by Big Type 5.1 Global Erythropoietin (EPO) Drugs Revenue, Sales and Market Share by Big Type (2017-2022) 5.1.1 Global Erythropoietin (EPO) Drugs Sales and Market Share by Big Type (2017-2022) 5.1.2 Global Erythropoietin (EPO) Drugs Revenue and Market Share by Big Type (2017-2022) 5.2 Epoetin-alfa Sales Growth Rate and Price 5.2.1 Global Epoetin-alfa Sales Growth Rate (2017-2022) 5.2.2 Global Epoetin-alfa Price (2017-2022) 5.3 Darbepoetin-alfa Sales Growth Rate and Price 5.3.1 Global Darbepoetin-alfa Sales Growth Rate (2017-2022) 5.3.2 Global Darbepoetin-alfa Price (2017-2022) 5.4 Epoetin-beta Sales Growth Rate and Price 5.4.1 Global Epoetin-beta Sales Growth Rate (2017-2022) 5.4.2 Global Epoetin-beta Price (2017-2022) 5.5 Others Sales Growth Rate and Price 5.5.1 Global Others Sales Growth Rate (2017-2022) 5.5.2 Global Others Price (2017-2022) 6 Global Erythropoietin (EPO) Drugs Market Segment by Big Application 6.1 Global Erythropoietin (EPO) Drugs Sales Market Share by Big Application (2017-2022) 6.2 Anemia Sales Growth Rate (2017-2022) 6.3 Kidney Disorders Sales Growth Rate (2017-2022) 6.4 Other Sales Growth Rate (2017-2022) 7 Global Erythropoietin (EPO) Drugs Forecast 7.1 Global Erythropoietin (EPO) Drugs Revenue, Sales and Growth Rate (2022-2027) 7.2 Erythropoietin (EPO) Drugs Market Forecast by Regions (2022-2027) 7.2.1 North America Erythropoietin (EPO) Drugs Market Forecast (2022-2027) 7.2.2 Europe Erythropoietin (EPO) Drugs Market Forecast (2022-2027) 7.2.3 China Erythropoietin (EPO) Drugs Market Forecast (2022-2027) 7.2.4 Japan Erythropoietin (EPO) Drugs Market Forecast (2022-2027) 7.2.5 Southeast Asia Erythropoietin (EPO) Drugs Market Forecast (2022-2027) 7.2.6 Other Regions Erythropoietin (EPO) Drugs Market Forecast (2022-2027) 7.3 Erythropoietin (EPO) Drugs Market Forecast by Type (2022-2027) 7.3.1 Global Erythropoietin (EPO) Drugs Sales Forecast by Type (2022-2027) 7.3.2 Global Erythropoietin (EPO) Drugs Market Share Forecast by Type (2022-2027) 7.4 Erythropoietin (EPO) Drugs Market Forecast by Application (2022-2027) 7.4.1 Global Erythropoietin (EPO) Drugs Sales Forecast by Application (2022-2027) 7.4.2 Global Erythropoietin (EPO) Drugs Market Share Forecast by Application (2022-2027) 8 Market Analysis 8.1.1 Market Overview 8.1.2 Market Opportunities 8.1.3 Market Risk 8.1.4 Market Driving Force 8.1.5 Porter's Five Forces Analysis 8.1.6 SWOT Analysis 9 Erythropoietin (EPO) Drugs Related Market Analysis 9.1 Upstream Analysis 9.1.1 Macro Analysis of Upstream Markets 9.1.2 Key Players in Upstream Markets 9.1.3 Upstream Market Trend Analysis 9.1.4 Erythropoietin (EPO) Drugs Manufacturing Cost Analysis 9.2 Downstream Market Analysis 9.2.1 Macro Analysis of Down Markets 9.2.2 Key Players in Down Markets 9.2.3 Downstream Market Trend Analysis 9.2.4 Sales Channel, Distributors, Traders and Dealers 10 Research Findings and Conclusion

List of Tables and Figures Figure Product Picture Erythropoietin (EPO) Drugs Figure Market Concentration Ratio and Market Maturity Analysis of Erythropoietin (EPO) Drugs Figure Bottom-up and Top-down Approaches for This Report Figure Part of Our External Database Figure Part of Our External Database Figure Key Executives Interviewed Table Global Erythropoietin (EPO) Drugs Market Size by Big Type Figure Global Market Share of Erythropoietin (EPO) Drugs by Big Type in 2021 Figure Epoetin-alfa Picture (2017-2022) Figure Darbepoetin-alfa Picture (2017-2022) Figure Epoetin-beta Picture (2017-2022) Global Erythropoietin (EPO) Drugs Market Size by Big Application Table Global Erythropoietin (EPO) Drugs Market Size by Application Figure Global Erythropoietin (EPO) Drugs Market Share by Big Application in 2021 Figure Anemia Picture Figure Kidney Disorders Picture Figure Other Picture Table Global Erythropoietin (EPO) Drugs Comparison by Regions (M USD) （2017-2027） Figure Global Erythropoietin (EPO) Drugs Market Size (Million US$) (2017-2027) Figure North America Erythropoietin (EPO) Drugs Revenue (Million US$) Growth Rate (2017-2027) Figure Europe Erythropoietin (EPO) Drugs Revenue (Million US$) Growth Rate (2017-2027) Figure China Erythropoietin (EPO) Drugs Revenue (Million US$) Growth Rate (2017-2027) Figure Japan Erythropoietin (EPO) Drugs Revenue (Million US$) Growth Rate (2017-2027) Figure Southeast Asia Erythropoietin (EPO) Drugs Revenue (Million US$) Growth Rate (2017-2027) Table Business Impact Assessment - Covid-19 Table Market Trends and Erythropoietin (EPO) Drugs Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global Erythropoietin (EPO) Drugs Sales by Manufacturer (2017-2022) Figure Global Erythropoietin (EPO) Drugs Sales Market Share by Manufacturer in 2021 Table Global Erythropoietin (EPO) Drugs Revenue by Manufacturer (2017-2022) Figure Global Erythropoietin (EPO) Drugs Revenue Market Share by Manufacturer in 2021 Table Global Erythropoietin (EPO) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Erythropoietin (EPO) Drugs Manufacturer (Revenue) Market Share in 2021 Figure Top 10 Erythropoietin (EPO) Drugs Manufacturer (Revenue) Market Share in 2021 Table Date of Key Manufacturers Enter into Erythropoietin (EPO) Drugs Market Table Key Manufacturers Erythropoietin (EPO) Drugs Product Type Table Mergers & Acquisitions Planning Table Amgen Company Profile Table Erythropoietin (EPO) Drugs Product Introduction, Application and Specification of Amgen Table Erythropoietin (EPO) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022 Table Company One Main Business Table Company One Recent Development Table Johnson & Johnson Company Profile Table Erythropoietin (EPO) Drugs Product Introduction, Application and Specification of Johnson & Johnson Table Erythropoietin (EPO) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Johnson & Johnson Recent Development Table Roche Company Profile Table Erythropoietin (EPO) Drugs Product Introduction, Application and Specification of Roche Table Erythropoietin (EPO) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Roche Main Business Table Roche Recent Development Table Galenica Company Profile Table Erythropoietin (EPO) Drugs Product Introduction, Application and Specification of Galenica Table Erythropoietin (EPO) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Galenica Main Business Table Galenica Recent Development Table Galenica Main Business Table Galenica Recent Development Table Emcure Company Profile Table Erythropoietin (EPO) Drugs Product Introduction, Application and Specification of Emcure Table Erythropoietin (EPO) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Emcure Main Business Table Emcure Recent Development Table Kyowa Hakko Kirin Company Profile Table Erythropoietin (EPO) Drugs Product Introduction, Application and Specification of Kyowa Hakko Kirin Table Erythropoietin (EPO) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Kyowa Hakko Kirin Main Business Table Kyowa Hakko Kirin Recent Development Table 3SBio Company Profile Table Erythropoietin (EPO) Drugs Product Introduction, Application and Specification of 3SBio Table Erythropoietin (EPO) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table 3SBio Main Business Table 3SBio Recent Development Table Biocon Company Profile Table Erythropoietin (EPO) Drugs Product Introduction, Application and Specification of Biocon Table Erythropoietin (EPO) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table Biocon Main Business Table Biocon Recent Development Table LG Life Sciences Company Profile Table Erythropoietin (EPO) Drugs Product Introduction, Application and Specification of LG Life Sciences Table Erythropoietin (EPO) Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022 Table LG Life Sciences Main Business Table LG Life Sciences Recent Development Figure Global Erythropoietin (EPO) Drugs Sales and Growth Rate (2017-2022) Figure Global Erythropoietin (EPO) Drugs Revenue and Growth Rate (2017-2022) Table Global Erythropoietin (EPO) Drugs Sales by Regions (2017-2022) Figure Global Erythropoietin (EPO) Drugs Sales Market Share by Regions in 2021 Table Global Erythropoietin (EPO) Drugs Revenue by Regions (2017-2022) Figure Global Erythropoietin (EPO) Drugs Revenue Market Share by Regions in 2021 Figure North America Erythropoietin (EPO) Drugs Sales and Growth Rate (2017-2022) Figure Europe Erythropoietin (EPO) Drugs Sales and Growth Rate (2017-2022) Figure China Erythropoietin (EPO) Drugs Sales and Growth Rate (2017-2022) Figure Japan Erythropoietin (EPO) Drugs Sales and Growth Rate (2017-2022) Figure Southeast Asia Erythropoietin (EPO) Drugs Sales and Growth Rate (2017-2022) Figure Other Regions Erythropoietin (EPO) Drugs Sales and Growth Rate (2017-2022) Table Global Erythropoietin (EPO) Drugs Sales by Big Type (2017-2022) Table Global Erythropoietin (EPO) Drugs Sales Market Share by Big Type (2017-2022) Figure Global Erythropoietin (EPO) Drugs Sales Market Share by Big Type in 2019 Table Global Erythropoietin (EPO) Drugs Revenue by Big Type (2017-2022) Table Global Erythropoietin (EPO) Drugs Revenue Market Share by Big Type (2017-2022) Table Global Erythropoietin (EPO) Drugs Revenue Market Share by Big Type in 2019 Figure Global Epoetin-alfa Sales Growth Rate (2017-2022) Figure Global Epoetin-alfa Price (2017-2022) Figure Global Darbepoetin-alfa Sales Growth Rate (2017-2022) Figure Global Darbepoetin-alfa Price (2017-2022) Figure Global Epoetin-beta Sales Growth Rate (2017-2022) Figure Global Epoetin-beta Price (2017-2022) Figure Global Others Sales Growth Rate (2017-2022) Table Global Erythropoietin (EPO) Drugs Sales by Big Application (2017-2022) Table Global Erythropoietin (EPO) Drugs Sales Market Share by Big Application (2017-2022) Figure Global Erythropoietin (EPO) Drugs Sales Market Share by Big Application in 2019 Figure Global Anemia Sales Growth Rate (2017-2022) Figure Global Kidney Disorders Sales Growth Rate (2017-2022) Figure Global Other Sales Growth Rate (2017-2022) Figure Global Erythropoietin (EPO) Drugs Sales and Growth Rate (2022-2027) Figure Global Erythropoietin (EPO) Drugs Revenue and Growth Rate (2022-2027) Table Global Erythropoietin (EPO) Drugs Sales Forecast by Regions (2022-2027) Table Global Erythropoietin (EPO) Drugs Market Share Forecast by Regions (2022-2027) Figure North America Sales Erythropoietin (EPO) Drugs Market Forecast (2022-2027) Figure Europe Sales Erythropoietin (EPO) Drugs Market Forecast (2022-2027) Figure China Sales Erythropoietin (EPO) Drugs Market Forecast (2022-2027) Figure Japan Sales Erythropoietin (EPO) Drugs Market Forecast (2022-2027) Figure Southeast Asia Sales Erythropoietin (EPO) Drugs Market Forecast (2022-2027) Figure Other Regions Sales Erythropoietin (EPO) Drugs Market Forecast (2022-2027) Table Global Erythropoietin (EPO) Drugs Sales Forecast by Type (2022-2027) Table Global Erythropoietin (EPO) Drugs Market Share Forecast by Type (2022-2027) Table Global Erythropoietin (EPO) Drugs Sales Forecast by Application (2022-2027) Table Global Erythropoietin (EPO) Drugs Market Share Forecast by Application (2022-2027) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Upstream Markets Table Key Players in Upstream Markets Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Erythropoietin (EPO) Drugs Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Sales Channel Figure North America Erythropoietin (EPO) Drugs Sales (K Units) Growth Rate Forecast (2021-2025) Figure North America Erythropoietin (EPO) Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025) Figure Europe Erythropoietin (EPO) Drugs Sales (K Units) Growth Rate Forecast (2021-2025) Figure Europe Erythropoietin (EPO) Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025) Figure Japan Erythropoietin (EPO) Drugs Production (K Units) Growth Rate Forecast (2021-2025) Figure Japan Erythropoietin (EPO) Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025) Figure China Erythropoietin (EPO) Drugs Production (K Units) Growth Rate Forecast (2021-2025) Figure China Erythropoietin (EPO) Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Amgen Johnson & Johnson Roche Galenica Emcure Kyowa Hakko Kirin 3SBio